Mepolizumab 2.5 mg/kg vs mepolizumab 0.55 mg/kg
Histological improvement (dichotomous) · active EoE pediatric patients
It is very uncertain whether mepolizumab 2.5 mg/kg changes histological improvement at 12 weeks (dichotomous) compared with mepolizumab 0.55 mg/kg (very low certainty).
1 finding from 1 review
- RR 2.14 [0.79, 5.79]1 study · 39 participantsVery low